North American Fetal Therapy Network (NAFTNet)

About North American Fetal Therapy Network

The North American Fetal Therapy Network (NAFTNet) is a nonprofit, voluntary association of 18 medical centers in both the United States and Canada that perform advanced in-utero fetal therapeutic procedures. The primary mission of NAFTNet is to provide a cooperative clinical research network to study the natural history of fetal disease and to develop therapeutic prenatal interventions to improve pregnancy outcomes. NAFTNet provides an umbrella organization to assist the various medical centers that practice fetal medicine, promote cooperation between these centers and foster research in the field of fetal therapy.

Facts about North American Fetal Therapy Network
  • Industry : Healthcare

Here you will find North American Fetal Therapy Network (NAFTNet)

Last viewed contents

Viruses on the run - ETH Zurich Professor Ari Helenius awarded Benoist Prize

Viruses on the run - ETH Zurich Professor Ari Helenius awarded Benoist Prize

New approach in the treatment of non-alcoholic fatty liver disease - Resistant starch, such as that found in green bananas, may play an important role in treatment of non-alcoholic fatty liver disease in the future

New approach in the treatment of non-alcoholic fatty liver disease - Resistant starch, such as that found in green bananas, may play an important role in treatment of non-alcoholic fatty liver disease in the future

New model could revolutionise the treatment of autoimmune disease as well as vaccine development - Paradigm shift in immunology: 'Adaptive Tolerance' balances autoimmune reaction

New model could revolutionise the treatment of autoimmune disease as well as vaccine development - Paradigm shift in immunology: 'Adaptive Tolerance' balances autoimmune reaction

Successful Outcome from European Clinical Pharmacokinetic Study Comparing SUBA-Itraconazole with Sporanox - HalcyGen to begin Marketing Authorisation Application for Regulators in Europe

Evotec Receives a Milestone Payment as Part of its Discovery Alliance with Boehringer Ingelheim

UF study strengthens concerns about long-term use of certain painkillers

Scientists at Almac and Queen’s University Belfast discover novel approach to treat cancer patients.

Restoring chemotherapy sensitivity by boosting microRNA levels

Restoring chemotherapy sensitivity by boosting microRNA levels

Bayer and Onyx Initiate Phase III Trial of Nexavar in Patients with Non-Responsive Thyroid Cancer

Centocor, Inc. - Horsham, USA

Centocor, Inc. - Horsham, USA

Advanced Cell Technology Announces Creation of Human Embryonic Stem Cell Lines Without the Destruction of Embryos - Breakthrough Approach Improves Efficiency to Levels Reported in the Conventional Stem Cell Derivation Techniques

Generex Biotechnology and Pevion Biotech announce plans for immunotherapeutic vaccine collaboration